Transfer of a gene that produces a mutant form of good cholesterol provides significantly better anti-plaque and anti-inflammation benefits than therapy using the “normal” HDL gene, according to a mouse study conducted by cardiology researchers at Cedars-Sinai Medical Center and reported in the Oct. 3 issue of the Journal of the American College of Cardiology.
Contrary to oral warfarin therapy, the use of subcutaneous low-molecular weight heparin (LMWH) has the advantage of stable dosing without the need of prothrombin time monitoring. Few randomized studies have compared the efficacy of LMWH with the least costly unfractionated heparin for the treatment of deep vein thrombosis (DVT). In the United States, 6 days of LMWH therapy for an 80 kg patient is estimated to cost $712, compared with $37 of unfractionated heparin.
The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis, according to a team of researchers at the Stanford University School of Medicine. Their findings will be published in the October issue of the Journal of Clinical Investigation.
Anti-cancer drug developer AmpliMed Corp. announced a clinical benefit rate of 44.4 percent for its lead drug candidate Amplimexon.
The hormone progestin, as a component of hormone replacement therapy (HRT) following menopause, appears to exacerbate deficits in hearing sensitivity and auditory speech processing, according to a research team at the Rochester School of Medicine and Dentistry in New York.
Estrens did build bone, but might also raise cancer risks, study finds. Experimental osteoporosis drugs called estrens do not perform as well as researchers had hoped, new animal studies suggest.
Study Finds No Increased Risk of Lymphoma or Tumors Associated with Anti-TNF Therapy Over Methotrexate Use Among Rheumatoid Arthritis Patients. Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.
They typically don’t survive as long as male patients, study finds. Women on long-term oxygen therapy for chronic obstructive pulmonary disease (COPD) are 54 percent more likely to die than male patients, a new study shows.
Every day we are exposed to external toxins from our environment and internal toxins produced as the byproduct of our digestive and metabolic processes. Toxic and unwanted inorgranic chemicals are found in our foods, water and air in the form of fertilizers, pesticides, heavy metals and other pollutants.
Although surgery is the most effective (and hence, the most widely used) breast cancer treatment method, there are several other ways of dealing with the disease, some are more powerful than the others. These include radiation therapy, chemotherapy or hormonal therapy, each of them with their own assets and downsides.